In the gravid human uterus, oxytocin induces smooth muscle cell contraction via transient receptor potential vanilloid 4 channel activation.

Summary

Using gravid human myometrium, the authors demonstrate that oxytocin-induced calcium influx and contraction require TRPV4 channel activation and OXTR–TRPV4 proximity. Oxytocin-resistant uterine atony exhibited reduced glycosylated OXTR and diminished OXTR–TRPV4 interactions, implicating a novel mechanism and suggesting TRPV4-focused therapeutics.

Key Findings

• TRPV4 and OXTR colocalize within <40 nm in gravid human myometrium and functionally interact.
• TRPV4 blockade or siRNA knockdown abolishes oxytocin-induced calcium influx and contraction; voltage-gated calcium channel blockade does not.
• Oxytocin-resistant uterine atony tissue shows reduced glycosylated OXTR and diminished OXTR–TRPV4 proximity ligation signals.

Clinical Implications

For obstetric anesthesia and peripartum care, TRPV4 antagonists could be explored as tocolytics to prevent or treat preterm labor, while strategies enhancing OXTR–TRPV4 coupling may address oxytocin-resistant uterine atony and postpartum hemorrhage.

Limitations

• Ex vivo/in vitro study without interventional clinical outcomes.
• Sample size and patient heterogeneity (e.g., parity, comorbidities) are not detailed; generalizability to laboring uterus requires study.

Future Directions

Evaluate TRPV4 modulators in translational models and early-phase trials; define biomarkers (e.g., OXTR glycosylation, OXTR–TRPV4 proximity) to stratify risk of atony or preterm labor.